Edition:
United States

La Jolla Pharmaceutical Co (LJPC.OQ)

LJPC.OQ on NASDAQ Stock Exchange Capital Market

16.16USD
19 Oct 2018
Change (% chg)

$-0.83 (-4.89%)
Prev Close
$16.99
Open
$17.06
Day's High
$17.28
Day's Low
$15.56
Volume
249,582
Avg. Vol
132,836
52-wk High
$41.24
52-wk Low
$15.56

Chart for

About

La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening diseases. LJPC-501 is its formulation of angiotensin II for the potential treatment of catecholamine-resistant... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $471.02
Shares Outstanding(Mil.): 26.23
Dividend: --
Yield (%): --

Financials

  LJPC.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -7.17 -- --
ROI: -85.25 1.96 12.83
ROE: -138.56 1.12 14.95

BRIEF-La Jolla Pharmaceutical Co Announces $125 Mln Royalty Financing Agreement With Healthcare Royalty Partners

* LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES $125 MILLION ROYALTY FINANCING AGREEMENT WITH HEALTHCARE ROYALTY PARTNERS Source text for Eikon: Further company coverage:

May 10 2018

BRIEF-La Jolla Pharmaceutical Quarterly Loss Per Share $2.22

* LA JOLLA PHARMACEUTICAL ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2018 AND RECENT CORPORATE PROGRESS

May 10 2018

Competitors

  Price Chg
Galectin Therapeutics Inc (GALT.OQ) $4.94 -0.04
Merck & Co., Inc. (MRK.N) $72.35 +0.14
Roche Holding Ltd. (ROG.S) CHF244.95 +6.40
Roche Holding Ltd. (RO.S) CHF245.20 +5.80
Novartis AG (NOVN.S) CHF87.04 +1.16
Celltrion, Inc. (068270.KS) ₩273,000.00 +12,500.00
Kyowa Hakko Kirin Co Ltd (4151.T) ¥2,051 -17.00
Astellas Pharma Inc (4503.T) ¥1,888 +19.00

Earnings vs. Estimates